Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 28 July 2025
First Online: 9 September 2025
Competing interests
: J.D. is a consultant for and on the Advisory Board of: Amgen, Novartis, Janssen. He also receives research support from Ono Therapeutics and Novartis, and royalties from Wolters Kluwer. P.K. and T.A.N. declare no competing interests.
